Timing for Intravenous Injection of Mesenchymal Stem Cells to Enhance Fracture Healing
Journal of Functional Biomaterials · 27.07.2026 · 17 (8) · 361
DOI: 10.3390/jfb17080361 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Functional Biomaterials, online erschienen am 27.07.2026. Verfasst von Kang-Il Kim und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopedic Surgery, Kyung Hee University Hospital at Gangdong, Kyung Hee University School of Medicine, Seoul 05278, Republic of Korea. Die Arbeit nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Kyung Hee University.
Abstract (Originalsprache)
When delivered intravenously, mesenchymal stem cells (MSCs) enhance fracture healing and can be injected at various time points, but the optimal timing remains unclear. This study aimed to clarify the optimal timing of MSC delivery to enhance the healing. For-ty-nine Wistar rats with femoral shaft fractures were randomized according to injection timing: immediately after fracture (group A, n = 14), 24 h after fracture (group B, n = 14), 7 days after fracture (group C, n = 14), and control group (group D, n = 7). Allogeneic bone-marrow-derived MSCs (5.0 × 106 cells) were administered intravenously. Rats were euthanized at 6 weeks post-fracture for analysis. In each group, seven rats were evaluated for new bone formation and histological examination. Another seven rats in group A, B, and C were evaluated for VEGF, TGF-β1, and BMP-2 expression. Group C showed significantly higher new bone formation than groups A, B and D (p = 0.017, p = 0.003, and p = 0.005). Histological grades were higher in group C than in groups D (p = 0.018). In Western blot analysis, VEGF and BMP-2 were higher in group C (p < 0.05). Real-time polymerase chain reaction revealed higher VEGF and TGF-β1 RNA expression in group C (p < 0.05). MSCs administration at 7 days post-fracture is suggested to be the optimal timing for intravenous injection to enhance fracture healing in a rat long bone fracture model.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Orthopedic Surgery, Kyung Hee University Hospital at Gangdong, Kyung Hee University School of Medicine, Seoul 05278, Republic of Korea.
- Center for Advanced Regenerative Medicine, Kyung Hee University Hospital at Gangdong, Seoul 05278, Republic of Korea.
- Department of Medicine, Graduate school of Kyung Hee University, Seoul 02453, Republic of Korea.
ORCID-Profile: Myung-Seo Kim, Ki-Hyeok Ku
Förderung
- Kyung Hee University
Zitieren
APA
Kim, K. I., Jang, G. Y., Cho, K. Y., Kim, M. S., Chung, H. J., Cho, H. M., & Ku, K. H. (2026). Timing for Intravenous Injection of Mesenchymal Stem Cells to Enhance Fracture Healing. Journal of Functional Biomaterials, 17(8), 361. https://doi.org/10.3390/jfb17080361
Vancouver
Kim KI, Jang GY, Cho KY, Kim MS, Chung HJ, Cho HM, et al. Timing for Intravenous Injection of Mesenchymal Stem Cells to Enhance Fracture Healing. Journal of Functional Biomaterials. 2026;17(8):361. doi:10.3390/jfb17080361
BibTeX
@article{Kim2026,
author = {Kim, Kang-Il and Jang, Gi-Young and Cho, Kye-Youl and Kim, Myung-Seo and Chung, Hyun-Ju and Cho, Hyun-Mi and Ku, Ki-Hyeok},
title = {Timing for Intravenous Injection of Mesenchymal Stem Cells to Enhance Fracture Healing},
journal = {Journal of Functional Biomaterials},
year = {2026},
volume = {17},
number = {8},
pages = {361},
doi = {10.3390/jfb17080361}
}
EUVIMED